|
SMG7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.87805999999346E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.2638999999991E-05 |
| Normal-vs-Stage2 |
1.000170E-02 |
| Normal-vs-Stage3 |
1.95915999999796E-05 |
| Normal-vs-Stage4 |
6.599700E-03 |
| Stage1-vs-Stage2 |
3.212200E-01 |
| Stage1-vs-Stage3 |
4.370400E-01 |
| Stage1-vs-Stage4 |
7.101200E-01 |
| Stage2-vs-Stage3 |
1.522760E-01 |
| Stage2-vs-Stage4 |
6.560600E-01 |
| Stage3-vs-Stage4 |
4.138400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.59454999999475E-05 |
| Normal-vs-AfricanAmerican |
2.964200E-01 |
| Normal-vs-Asian |
9.761600E-04 |
| Caucasian-vs-AfricanAmerican |
4.829700E-02 |
| Caucasian-vs-Asian |
7.368000E-01 |
| AfricanAmerican-vs-Asian |
1.105350E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.646400E-04 |
| Normal-vs-Female |
4.71560000003812E-06 |
| Male-vs-Female |
3.934600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.50740000000038E-05 |
| Normal-vs-Age(41-60Yrs) |
4.3714000000028E-05 |
| Normal-vs-Age(61-80Yrs) |
3.977100E-03 |
| Normal-vs-Age(81-100Yrs) |
7.113500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.095800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.537800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.802600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.122000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.185000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.919600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.354500E-02 |
| Classical-VS-Follicular |
4.867000E-01 |
| Classical-VS-Other |
6.677800E-01 |
| Classical-VS-Normal |
1.435720E-04 |
| Tall-VS-Follicular |
1.486340E-02 |
| Tall-VS-Other |
5.130600E-01 |
| Tall-VS-Normal |
3.88709999998849E-06 |
| Follicular-VS-Other |
5.181800E-01 |
| Follicular-VS-Normal |
4.239500E-03 |
| Other-VS-Normal |
5.942000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.849410E-04 |
| Normal-vs-N1 |
4.55720000003268E-06 |
| N0-vs-N1 |
5.620200E-02 |
|
|
